Ansbert Gadicke

Affiliations

  • Large Shareholder, Director at Allovir Inc. (ALVR), 2022-08-01
  • Director at Cullinan Oncology Inc. (CGEM), 2022-06-23
  • Large Shareholder at Iteos Therapeutics Inc. (ITOS), 2022-01-06
  • Large Shareholder at Entrada Therapeutics Inc. (TRDA), 2021-11-04
  • Large Shareholder at Repare Therapeutics Inc. (RPTX), 2021-06-28
  • Large Shareholder at Harpoon Therapeutics Inc. (HARP), 2021-06-02
  • Large Shareholder at Werewolf Therapeutics Inc. (HOWL), 2021-05-06
  • Large Shareholder at Oncorus Inc. (ONCR), 2020-10-08
  • Large Shareholder at Dyne Therapeutics Inc. (DYN), 2020-09-23
  • Large Shareholder, Director at Tcr2 Therapeutics Inc. (TCRR), 2019-02-21
  • Large Shareholder at Rhythm Pharmaceuticals Inc. (RYTM), 2017-10-11
  • Director at Radius Health Inc. (RDUS), 2017-02-22
  • Director at Chiasma Inc (CHMA), 2016-06-13
  • Large Shareholder at Syndax Pharmaceuticals Inc (SNDX), 2016-03-09
  • Large Shareholder at Cerecor Inc. (CERC), 2015-10-20
  • Large Shareholder at Trivascular Technologies Inc. (TRIV), 2014-04-23
  • Large Shareholder at Aratana Therapeutics Inc. (PETX), 2014-03-12
  • Large Shareholder at Epizyme Inc. (EPZM), 2014-02-11
  • Large Shareholder at Conatus Pharmaceuticals Inc (CNAT), 2013-08-01
  • Other at Pacira Pharmaceuticals Inc. (PCRX), 2013-03-13
  • Large Shareholder at Kalobios Pharmaceuticals Inc (KBIO), 2013-02-07
  • Large Shareholder at Somaxon Pharmaceuticals Inc. (SOMX), 2012-07-10
  • Director at Verastem Inc. (VSTM), 2012-03-08
  • Large Shareholder at Zalicus Inc. (ZLCS), 2011-10-28
  • Other at Enteromedics Inc (ETRM), 2010-12-15
  • Large Shareholder at Pharmathene Inc (PIP), 2010-11-05
  • Large Shareholder at Aryx Therapeutics Inc. (ARYX), 2010-10-04
  • Large Shareholder at Senorx Inc (SENO), 2010-06-29
  • Other at Aveo Pharmaceuticals Inc (AVEO), 2010-03-18
  • Large Shareholder at Metabasis Therapeutics Inc (MBRX), 2010-01-29
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
HOWL $16.00 245,000 Large Shareholder 6,672,183 2021-05-04 Filing
CGEM $21.00 300,000 Large Shareholder, Director 7,913,887 2021-01-12 Filing
ONCR $15.00 151,224 Large Shareholder 2,377,025 2020-10-06 Filing
ONCR $15.00 173,776 Large Shareholder 2,849,453 2020-10-06 Filing
ITOS $19.00 160,000 Large Shareholder, Director 2,355,557 2020-07-28 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ITOS $42.03 30,347 Large Shareholder 4,484,728 2022-01-05 Filing
ITOS $46.47 12,829 Large Shareholder 4,515,075 2022-01-04 Filing
ITOS $45.32 11,318 Large Shareholder 4,527,904 2022-01-04 Filing
ITOS $43.20 32,396 Large Shareholder 4,539,222 2022-01-04 Filing
ITOS $42.05 158,579 Large Shareholder 4,571,618 2022-01-04 Filing